Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Gastroenterology
Disease Category: Gastrointestinal Diseases and Disorders
Trial Information
A study to prevent the reoccurrence of diverticulitis.
This study will examine the study drug in all patients with diverticulitis that has resulted in at least one episode of diverticulosis within the past 24 months. The primary purpose of the study is to compare the time that the study drugs can prevent an episode of recurrence of diverticulitis (although there is no guarantee that a recurrence of diverticulitis will be prevented).
Patient Inclusion Criteria:
- Patient must have at least one documented attack of acute diverticulitis in the previous 24 months that has been clinically resolved with colonic resection.
Documentation must include a verifiable report confirming acute diverticulitis (ex: CT scan, MRI, Ultrasound, endoscopy of the sigmoid colon)
- Must be 18 years of age.
Patient Exclusion Criteria:
- female and pregnant, planning to become pregnant or breast feeding
- Past history of colo-rectal surgery (excluding removal of colon polyps
Chris McNett, CCRC, Senior Regulatory Document Specialist
Borgess Research Institute
1521 Gull Road, North Professional Building, Suite 003
Kalamazoo, MI 49048
Phone: 269-226-4803
Fax: 269-226-6696
EMail: chrismcnett@borgess.com
View Google Map
Research Center Information: Borgess Research Institute
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
